Institute for Glycomics, Gold Coast Campus, Griffith University, Queensland 4222, Australia
E-mail:firstname.lastname@example.org Fax: 61 (0)7 5552 8220 Tel: 61 (0)7 5552 8033
Western Australian Institute for Medical Research and Centre for Medical Research, The University of Western Australia, Medical Research Foundation Building, Rear 50 Murray Street, Perth, Australia
E-mail:email@example.com Fax: 61 (0)8 9224 0332 Tel: 61 (0)8 9224 0330
The application of gold in medicine is traceable for several thousand years and Au(I) compounds have been used clinically to treat rheumatoid arthritis since the last century. Recently research into gold-based drugs for a range of human diseases has seen a renaissance. Old as well as new Au(I) and Au(III) compounds have been used and designed with an aim of targeting cellular components that are implicated in the onset or progression of cancers, rheumatoid arthiritis, viral and parasitic diseases. In addition, new disease targets have been found for gold compounds that have given insight into the mechanism of action of these compounds, as well as in the molecular pathophysiology of human diseases. Here we discuss the rationale for the design and use of gold compounds that have specific and selective targets in cells to alleviate the symptoms of a range of human diseases. We summarise the most recent findings in this research and our own discoveries to show that gold compounds can be developed to become versatile and powerful drugs for diseases caused by dysfunction of selenol and thiol containing proteins.
You have access to this article
Please wait while we load your content...
Something went wrong. Try again?